None

StaffCorner

☰
03 Nov, 2021 05:49 PM

WHO approves Indian ICMR & Bharat Biotech developed Covaxin

WHO approves Indian ICMR & Bharat Biotech developed Covaxin

The World Health Organization has finally granted Covaxin an emergency use listing. Covaxin is India's indigenous COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

Technical Advisory Group, convened by WHO & made up of regulatory experts from around the world, has determined that Covaxin vaccine meets WHO standards for protection against COVID, that benefit of the vaccine far outweighs risks & the vaccine can be used across the world: 

The covaxin vaccine was also reviewed by WHO’s Strategic Advisory Group of Experts on Immunization (SAGE), and recommended use of this vaccine in two doses, with a dose interval of four weeks, in all age groups 18 and above:

The approval means that the vaccine will be recognised by other countries and those vaccinated by covaxin will not be required for self-quarantine or face restrictions when travelling abroad.

The emergency listing, or EUL, comes at the end of a lengthy and rigorous review period - manufacturers Bharat Biotech first applied in April and provided required data in July - that involves assurances about the vaccine's safety, efficacy and stability, as well as checks of production facilities.




Whatsapp Share Button

βŒ‚ Go to StaffCorner.com Home Page



Latest in Important News
Latest in Other News Sections


StaffCorner brings you the latest authentic Central Government Employees News.
About us | Privacy Policy | Terms and Conditions | Archives